ArcticZymes Technologies ASA (OSL:AZT)

Theseus Pharmaceuticals Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	168.76	170.95	180.89	178.8	200.42	140.18
Short-Term Investments	73.94	72.98	68.97	65.37	-	-
Cash & Short-Term Investments	242.7	243.94	249.86	244.16	200.42	140.18
Cash Growth	-0.11%	-2.37%	2.33%	21.82%	42.98%	348.01%
Accounts Receivable	16.47	20.53	13.78	11.59	20.28	10.58
Other Receivables	5.18	2.25	0.85	1.45	5.11	19.66
Receivables	21.65	22.77	14.64	13.04	25.39	30.24
Inventory	15.5	15.84	12.87	7.08	6.88	3.89
Prepaid Expenses	-	1.76	2	3.94	0.73	0.47
Other Current Assets	2.94	0.92	0.62	1.03	-	-0
Total Current Assets	282.79	285.23	279.99	269.25	233.42	174.77
Property, Plant & Equipment	21.55	22.07	27.33	29.32	28.38	13.57
Other Intangible Assets	33.38	11.2	9.61	3.46	-	-
Long-Term Deferred Tax Assets	4.73	3.79	5.9	11.24	20.52	33.14
Long-Term Deferred Charges	-	22.04	16.48	5.78	1.79	0.42
Other Long-Term Assets	0.87	0.95	-	-	-0	0.01
Total Assets	343.32	345.27	339.32	319.04	284.11	221.91
Accounts Payable	3.51	5.12	4.54	5.59	5.8	3.46
Accrued Expenses	9.56	7	10.98	10.91	13.69	9
Current Portion of Leases	3.1	3.74	4.17	3.73	3.1	2.37
Other Current Liabilities	-	0.81	1.92	3.72	2.21	1.16
Total Current Liabilities	16.17	16.66	21.61	23.95	24.79	15.99
Long-Term Leases	4.85	4.36	8.41	10.35	14.47	9.6
Other Long-Term Liabilities	-	-0	0	-0	-	-0
Total Liabilities	21.02	21.02	30.03	34.3	39.27	25.58
Common Stock	51.07	51.07	50.87	50.57	50.37	48.34
Additional Paid-In Capital	265.77	265.77	263.95	261.66	260.26	151.04
Retained Earnings	5.46	7.41	-5.52	-27.49	-65.78	-5.01
Comprehensive Income & Other	-	-	-	0	0	-
Total Common Equity	322.3	324.25	309.3	284.74	244.85	194.37
Minority Interest	-	-	-	-	-	1.97
Shareholders' Equity	322.3	324.25	309.3	284.74	244.85	196.33
Total Liabilities & Equity	343.32	345.27	339.32	319.04	284.11	221.91
Total Debt	7.95	8.1	12.59	14.08	17.57	11.96
Net Cash (Debt)	234.76	235.84	237.27	230.08	182.86	128.22
Net Cash Growth	1.02%	-0.61%	3.13%	25.83%	42.62%	739.60%
Net Cash Per Share	4.63	4.62	4.67	4.52	3.65	2.61
Filing Date Shares Outstanding	51.07	51.07	50.87	50.57	50.37	48.33
Total Common Shares Outstanding	51.07	51.07	50.87	50.57	50.37	48.33
Working Capital	266.61	268.57	258.38	245.29	208.63	158.78
Book Value Per Share	6.31	6.35	6.08	5.63	4.86	4.02
Tangible Book Value	288.92	313.05	299.69	281.28	244.85	194.37
Tangible Book Value Per Share	5.66	6.13	5.89	5.56	4.86	4.02
Machinery	-	26.15	25.22	23.55	18.76	61.64

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.